Abstract
MALT lymphoma, especially of extragastric origin, is thought to be associated with an underlying autoimmune disease (AD) in a significant proportion of patients. No systematic assessment of the clinical characteristics of MALT lymphoma arising in AD as opposed to patients without AD has been performed so far. Therefore, all patients diagnosed and treated for MALT lymphoma at our institution have prospectively undergone routine clinical and serological assessment for AD since 1997. In total, 158 patients were available for analysis, and 61 out of 158 patients (39%) were diagnosed with an underlying AD. Patients with AD were predominantly women and significantly younger at lymphoma diagnosis (56 versus 67 years, P=0.004), with a significantly higher rate of extragastric lymphomas (P=0.012). Furthermore, lymphomas in these patients showed a lower frequency of trisomy 3 (P=0.04) and a significantly lower response rate to Helicobacter pylori eradication therapy in the case of gastric lymphomas (P=0.03). All other parameters including estimated median time to relapse were comparable between both groups. Our data suggest that patients with AD develop MALT lymphoma significantly earlier in life. The clinical course, however, does not appear to be adversely influenced by the presence of AD, as neither rate of relapse nor times to relapse or survival are significantly different.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Isaacson P, Wright DH . Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer 1983; 52: 1410–1416.
Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Mod Pathol 2000; 13: 193–207.
Pileri SA, Milani M, Fraternali-Orcioni G, Sabattini E . From the R.E.A.L. Classification to the upcoming WHO scheme: a step toward universal categorization of lymphoma entities? Ann Oncol 1998; 9: 607–612.
Isaacson PG . Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999; 10: 637–645.
Neubauer A, Thiede C, Morgner A, Alpen B, Ritter M, Neubauer B et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997; 89: 1350–1355.
Roggero E, Zucca E, Cavalli F . Gastric mucosa-associated lymphoid tissue lymphomas: more than a fascinating model. J Natl Cancer Inst 1997; 89: 1328–1330.
Thiede C, Wundisch T, Neubauer B, Alpen B, Morgner A, Ritter M et al. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: results of an ongoing multicenter trial. Recent Results Cancer Res 2000; 156: 125–133.
Janunger KG, Hafstrom L, Glimelius B . Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg 2002; 168: 597–608.
Nakamura T, Nakamura S, Yonezumi M, Suzuki T, Matsuura A, Yatabe Y et al. Helicobacter pylori and the t(11;18)(q21;q21) translocation in gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type. Jpn J Cancer Res 2000; 91: 301–309.
Yeh KH, Kuo SH, Chen LT, Mao TL, Doong SL, Wu MS et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood 2005; 106: 1037–1041.
Raderer M, Vorbeck F, Formanek M, Osterreicher C, Valencak J, Penz M et al. Importance of extensive staging in patients with mucosa-associated lymphoid tissue (MALT)-type lymphoma. Br J Cancer 2000; 83: 454–457.
Lecuit M, Abachin E, Martin A, Poyart C, Pochart P, Suarez F et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004; 350: 239–248.
Cerroni L, Zochling N, Putz B, Kerl H . Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997; 24: 457–461.
Ferreri AJ, Guidoboni M, Ponzoni M, De Conciliis C, Dell'Oro S, Fleischhauer K et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004; 96: 586–594.
Zinzani PL, Magagnoli M, Galieni P, Martelli M, Poletti V, Zaja F et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999; 17: 1254.
Arima S, Ohsato K, Hisatsugu T, Shimura H . Multicentre randomised study of adjuvant chemotherapy with mitomycin C and tegafur or tegafur-uracil in gastric cancer. Eur J Surg 1994; 160: 227–232.
Caletti G, Togliani T, Fusaroli P, Sabattini E, Khodadadian E, Gamberi B et al. Consecutive regression of concurrent laryngeal and gastric MALT lymphoma after anti-Helicobacter pylori therapy. Gastroenterology 2003; 124: 537–543.
Grunberger B, Wohrer S, Streubel B, Formanek M, Petkov V, Puespoek A et al. Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma. J Clin Oncol 2006; 24: 1370–1375.
Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392.
Group ILS . A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909–3918.
Musshoff K . Clinical staging classification of non-Hodgkin's lymphomas (author's translation). Strahlentherapie 1977; 153: 218–221.
Radaszkiewicz T, Dragosics B, Bauer P . Gastrointestinal malignant lymphomas of the mucosa-associated lymphoid tissue: factors relevant to prognosis. Gastroenterology 1992; 102: 1628–1638.
Streubel B, Seitz G, Stolte M, Birner P, Chott A, Raderer M . MALT lymphoma associated genetic aberrations occur at different frequencies in primary and secondary intestinal MALT lymphomas. Gut 2006; 55: 1581–1585.
Wohrer S, Streubel B, Bartsch R, Chott A, Raderer M . Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue lymphoma. Clin Cancer Res 2004; 10: 7179–7181.
Raderer M, Streubel B, Woehrer S, Puespoek A, Jaeger U, Formanek M et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005; 11: 3349–3352.
Raderer M, Osterreicher C, Machold K, Formanek M, Fiebiger W, Penz M et al. Impaired response of gastric MALT-lymphoma to Helicobacter pylori eradication in patients with autoimmune disease. Ann Oncol 2001; 12: 937–939.
Engels EA, Cerhan JR, Linet MS, Cozen W, Colt JS, Davis S et al. Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol 2005; 162: 1153–1161.
Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A et al. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 51–60.
Raderer M, Wohrer S, Streubel B, Troch M, Turetschek K, Jager U et al. Assessment of disease dissemination in gastric compared with extragastric mucosa-associated lymphoid tissue lymphoma using extensive staging: a single-center experience. J Clin Oncol 2006; 24: 3136–3141.
Thieblemont C, Berger F, Dumontet C, Moullet I, Bouafia F, Felman P et al. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed. Blood 2000; 95: 802–806.
Conconi A, Martinelli G, Thieblemont C, Ferreri AJ, Devizzi L, Peccatori F et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003; 102: 2741–2745.
Zhou Y, Ye H, Martin-Subero JI, Hamoudi R, Lu YJ, Wang R et al. Distinct comparative genomic hybridisation profiles in gastric mucosa-associated lymphoid tissue lymphomas with and without t(11;18)(q21;q21). Br J Haematol 2006; 133: 35–42.
Acknowledgements
This project was supported by the FWF (P19346-B12).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wöhrer, S., Troch, M., Streubel, B. et al. MALT lymphoma in patients with autoimmune diseases: a comparative analysis of characteristics and clinical course. Leukemia 21, 1812–1818 (2007). https://doi.org/10.1038/sj.leu.2404782
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2404782
Keywords
This article is cited by
-
Imaging of head and neck mucosa-associated lymphoid tissue lymphoma (MALToma)
Cancer Imaging (2021)
-
Primary oral mucosa-associated lymphoid tissue (MALT) lymphoma in patient with monoclonale gammopathy: a rare case report
BMC Oral Health (2021)
-
Lymphomas of the head and neck region: an update
Virchows Archiv (2019)
-
Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue
Clinical and Experimental Medicine (2018)
-
Novel developments in the pathogenesis and diagnosis of extranodal marginal zone lymphoma
Journal of Hematopathology (2017)